Questions Linger as Industry Rushes to Meet Jan. 1 Traceability Deadline
This article was originally published in The Gold Sheet
Executive Summary
As Jan. 1 deadline looms, there are questions about whether the pharmaceutical industry is fully prepared to implement tracing provisions of the Drug Supply Chain Security Act – and whether FDA is fully prepared to enforce the requirement, even at the risk of triggering drug shortages.